Feature|Videos|August 5, 2026

Meet the Moderator for the Next-Generation Bioconjugation Panel

Key Takeaways

  • Meet the moderator for this Peer Exchange.
  • Understand the topic for this peer-to-peer discussion.
SHOW MORE

Meet the moderator for this Peer Exchange on Next-Gen Bioconjugation: Designing-in Analytical Precision and Efficiency.

Sponsored by Waters Corporation

Colette Quinn, Senior Director and Portfolio Owner at Waters Corporation, introduces herself and welcomes viewers to this Peer Exchange. Her expertise lies in antibody drug conjugates—both cystine and lysine conjugated species.